Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to monitor the long-term safety and tolerability of tesaglitazar (0.5 and 1 mg) versus pioglitazone (15, 30 and 45 mg), with or without other oral anti-diabetic drugs, when administered up to 104weeks in an extension study from the GALLANT 6 study in patients with type 2 diabetes by evaluation of adverse events (AEs), laboratory variables, physical examination, cardiac evaluation, hypoglycaemic events, electrocardiogram (ECG), vital signs (blood pressure (BP) and pulse) and body weight.
Inclusion criteria
- type II diabetes mellitus